Correlates of lymphoproliferative responses to measles, mumps, and rubella (MMR) virus vaccines following MMR-II vaccination in healthy children

被引:23
作者
Dhiman, N
Ovsyannikova, IG
Jacobson, RM
Vierkant, RA
Pankratz, VS
Jacobsen, SJ
Poland, GA
机构
[1] Mayo Clin & Mayo Fdn, Mayo Vaccine Res Grp, Rochester, MN 55905 USA
[2] Mayo Clin & Mayo Fdn, Dept Pediat & Adolescent, Rochester, MN 55905 USA
[3] Mayo Clin & Mayo Fdn, Dept Hlth Sci, Rochester, MN 55905 USA
[4] Mayo Clin & Mayo Fdn, Program Translat Immunovirol & Biodef, Rochester, MN 55905 USA
关键词
cell-mediated immunity; measles; lymphoproliferative response; vaccine;
D O I
10.1016/j.clim.2004.12.010
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Cell-mediated immunity (CMI) to measles, mumps, and rubella viral antigens plays a critical role in providing long-term protection against these infectious diseases. We examined CMI by measuring lymphoproliferative response induced in response to stimulation with the above three antigens following two doses of measles, mumps, and rubella-II (MMR-II) vaccine in a randomly selected, population-based cohort of healthy children. We determined if a correlative and predictive intraclass relationship exists between CMI to the three components of MMR-II. We detected positive lymphoproliferative responses to measles, mumps, and rubella vaccines. Mumps vaccine used as an antigen had the highest median stimulation index followed by measles and rubella vaccines. The overall intraclass correlation value for lymphoproliferative response to measles, mumps, and rubella using Pearson's correlation was 0.61 (95% confidence interval = 0.56, 0.66). We observed a significant pairwise association to individual vaccine components between subjects in the upper and lower 10th percentile of immune response. This study demonstrates recall CMI post-MMR-II vaccination with significant intraclass correlation among the CMI responses to the three vaccine components. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:154 / 161
页数:8
相关论文
共 50 条
[1]  
ALATTAR I, 1995, PEDIATR INFECT DIS J, V14, P149, DOI 10.1097/00006454-199502000-00013
[2]   Development and durability of measles antigen-specific lymphoproliferative response after MMR vaccination [J].
Bautista-López, N ;
Ward, BJ ;
Mills, E ;
McCormick, D ;
Martel, N ;
Ratnam, S .
VACCINE, 2000, 18 (14) :1393-1401
[3]   SUSTAINED TRANSMISSION OF MUMPS IN A HIGHLY VACCINATED POPULATION - ASSESSMENT OF PRIMARY VACCINE FAILURE AND WANING VACCINE-INDUCED IMMUNITY [J].
BRISS, PA ;
FEHRS, LJ ;
PARKER, RA ;
WRIGHT, PF ;
SANNELLA, EC ;
HUTCHESON, RH ;
SCHAFFNER, W .
JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (01) :77-82
[4]   ANTIBODY-RESPONSE FOLLOWING MEASLES-MUMPS-RUBELLA VACCINE UNDER CONDITIONS OF CUSTOMARY USE [J].
BRUNELL, PA ;
WEIGLE, K ;
MURPHY, MD ;
SHEHAB, Z ;
COBB, E .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1983, 250 (11) :1409-1412
[5]   The influence of HLA genotype on AIDS [J].
Carrington, M ;
O'Brien, SJ .
ANNUAL REVIEW OF MEDICINE, 2003, 54 :535-551
[6]   MUMPS OUTBREAK IN A HIGHLY VACCINATED SCHOOL POPULATION - EVIDENCE FOR LARGE-SCALE VACCINATION FAILURE [J].
CHEEK, JE ;
BARON, R ;
ATLAS, H ;
WILSON, DL ;
CRIDER, RD .
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 1995, 149 (07) :774-778
[7]  
CHIBA Y, 1976, J IMMUNOL, V116, P12
[8]   Measles eradication in the Americas: Progress to date [J].
de Quadros, CA ;
Izurieta, H ;
Venczel, L ;
Carrasco, P .
JOURNAL OF INFECTIOUS DISEASES, 2004, 189 :S227-S235
[9]   Immune responses to measles and mumps vaccination of infants at 6, 9, and 12 months [J].
Gans, H ;
Yasukawa, L ;
Rinki, M ;
DeHovitz, R ;
Forghani, B ;
Beeler, J ;
Audet, S ;
Maldonado, Y ;
Arvin, AM .
JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (07) :817-826
[10]  
Gans HA, 1999, J IMMUNOL, V162, P5569